The SEC has delayed decisions on XRP ETF proposals from 21Shares, Grayscale, CoinShares, Bitwise, and others until October 19.The SEC has delayed decisions on XRP ETF proposals from 21Shares, Grayscale, CoinShares, Bitwise, and others until October 19.

The SEC delays making a decision on five different XRP ETF proposals

3 min read

The United States Securities and Exchange Commission (SEC) has reportedly delayed its decision on Canary Capital, CoinShares, Bitwise, Grayscale, and 21Shares. The regulatory agency aims to take cautionary measures before allowing new ETF products to exist in the country.

This announcement was made public after the SEC highlighted that it had extended its decision on the 21Shares Core XRP Trust from the set deadline of August 20, adding 60 days, setting the new deadline for October 19.

The delay will provide the regulatory agency ample time to seek public opinion on the proposal and assess any regulatory concerns associated with the Exchange Act, typically known as the Securities Exchange Act of 1934.

The 21Shares Trust initially filed its proposal on February 6, followed by an updated Amendment No. 1 submission on February 12. If the SEC ultimately disapproves of the 21Shares application after the October 19 deadline, it would represent a significant setback in the regulator’s legal review process for this product.

The SEC delays making a decision on XRP ETF proposals

Like the 21Shares XRP ETF proposal, the SEC has postponed its decisions on Grayscale, CoinShares, and Bitwise XRP ETF filings. The regulator’s new deadline for all these proposals remains October 19, with analysts anticipating the agency may handle them consistent with previous Bitcoin and Ethereum ETF reviews.

If this expectation holds, the SEC could issue final decisions on all eight pending spot ETF applications—including Franklin Templeton, REX-Osprey, WisdomTree, and five others—by October 18, the initial final deadline set for these unsettled funds.

Speculation also suggests that multiple ETFs, including Solana-based funds, could launch simultaneously, as the SEC has extended its review for Solana ETFs to align with the October deadline.

Despite the optimism that a decision will be made soon, BlackRock, the biggest asset manager in the world, announced just recently that it will not apply for an XRP ETF. Other pending applications for cryptocurrencies include Cardano, Hedera, Litecoin, Avalanche, Dogecoin, and PENGU.

The SEC extends review of altcoin ETFs

A similar approach was applied to several altcoin ETFs and various filings, according to reports from a reliable source, the SEC had extended the deadline for its review period for Truth Social’s Bitcoin and Ethereum ETF. These funds are not the only funds that will expose investors to Bitcoin and Ethereum because the agency had earlier approved Hashdex and Franklin Templeton’s funds, which have similar functions.

In addition, before the August 24 deadline, the agency had earlier delayed its decision on the CoinShares Litecoin ETF.

Considering the above Scenario, October 23 seems to be the final deadline for the SEC to decide whether to approve or disapprove this fund. Canary Capital and Grayscale are among the firms that have submitted an LTC ETF application.

The deadline will also feature the regulatory body’s decision on staking for the 21Shares Ethereum ETF and Grayscale’s Dogecoin ETF.

Don’t just read crypto news. Understand it. Subscribe to our newsletter. It's free.

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.4508
$1.4508$1.4508
-6.01%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11